0000000000099459

AUTHOR

B. Lo Sasso

ACE insertion/deletion polymorfism and longevity

research product

The implication of MBL deficient haplotypes in acute coronary syndrome

research product

B-type natriuretic peptides and thyroid disease

research product

Effect of vitamin supplementation on hyperhomocysteinemia and cardiovascular risk reduction

Homocysteine is a sulfur-containing aminoacid produced during methionine metabolism. Since 1969 the relationship between altered homocysteine metabolism and both coronary and peripheral atherotrombosis has been known; in recent years, experimental evidence has shown that elevated plasma concentrations of homocysteine are associated with an increased risk of atherosclerosis and cardiovascular ischemic events. Several mechanisms by which elevated homocysteine concentrations impair vascular function have been proposed, including impairment of endothelial function, production of reactive oxygen species and consequent oxidation of low-density lipoproteins. Folate and B vitamins, required for rem…

research product

A risk score derived from the analysis of a cluster of 27 serum inflammatory cytokines to predict long term outcome in patients with acute myocardial infarction: A pilot study

Objective. The aim of our study was to evaluate the clinical utility and prognostic significance of a cluster of 27 serum cytokines for risk stratification after myocardial infarction. Materials and Methods. We enrolled 33 consecutive patients admitted to our institution for acute myocardial infarction and prospectively followed. We evaluated traditional cardiovascular risk factors and assayed, during the acute phase, 27 serum cytokines (IL-1, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL -7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17, EOTAXIN, FGF, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, MIP-1ß, PDGF, RANTES, TNF-α, VEGF) potentially associated with cardiovascular risk. Patients were divided i…

research product

Clinical utilization of natriuretic peptide determination in acute congestive heart failure

research product